-
What To Expect in the 2024 Pharmaceutical Market
Suzanne Elvidge
January 12, 2024
The pharmaceutical market is growing fast. According to Statista.The largest market is oncology, predicted to be worth US$214.10 billion in 2024.
-
A Review of Oncology Biosimilars Products and Companies
David Orchard-Webb
May 12, 2022
Biologics and biosimilars are large and generally complex therapeutics produced from living organisms.
-
The Last Ten Shanghai STAR Market Pharmaceutical IPOs
David Orchard-Webb
March 16, 2022
The last ten biopharma companies that have IPO’d on the STAR Market (Shanghai Stock Exchange Science and Technology Innovation Board) are focused on oncology, synthetic biology, genomics, HIV & pain management...
-
NASDAQ Biopharma IPOs in the First Half of Q1 2022
David Orchard-Webb
March 01, 2022
So far in the first half of Q1 2022 seven biopharma companies have IPO’d on the NASDAQ.
-
Advancing oncology
Sarah Harding
March 18, 2021
With so much going on last year, you might be forgiven if you missed a ground-breaking announcement in November 2020 about the ‘Galleri blood test’.
-
Insights Into the Oncology Landscape in China
Neeta Ratanghayra
December 24, 2020
Significant increases in incidence rates have made cancer a high priority in China. Despite major government reforms to reduce cancer burdens, problems remain. To fulfill its agenda in cancer innovation, China is embracing new frontiers and opportunities.
-
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on M&A, IPO and Others
PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
-
Latest Data of InnoCare’s Robust Oncology Pipelines Presented at the 2022 ASCO Annual Meeting
PharmaSources.com
June 07, 2022
Latest data of InnoCare’s robust oncology pipeline were presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
-
Navigo Proteins Appoints Chris-Carol Bremer as Chief Development Officer
B3Cnewswire
February 07, 2022
Navigo Proteins, a premier protein engineering company developing novel scaffold protein-based affinity ligands called Affilin® molecules from its Precision Targeting Toolbox...
-
Global Recommendations for Colon Cancer Translated into Multiple Languages as NCCN Expands Arabic Resources
prnasia
December 23, 2021
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of newly-translated recommendations for treating colon cancer in Arabic...